Fulcrum Therapeutics (FULC) Other Gross PP&E Adjustments: 2019-2025
Historic Other Gross PP&E Adjustments for Fulcrum Therapeutics (FULC) over the last 7 years, with Sep 2025 value amounting to $13.4 million.
- Fulcrum Therapeutics' Other Gross PP&E Adjustments rose 15.32% to $13.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $50.5 million, marking a year-over-year increase of 15.90%. This contributed to the annual value of $11.8 million for FY2024, which is 13.97% up from last year.
- Per Fulcrum Therapeutics' latest filing, its Other Gross PP&E Adjustments stood at $13.4 million for Q3 2025, which was up 3.97% from $12.9 million recorded in Q2 2025.
- In the past 5 years, Fulcrum Therapeutics' Other Gross PP&E Adjustments registered a high of $14.6 million during Q4 2021, and its lowest value of $5.3 million during Q1 2022.
- In the last 3 years, Fulcrum Therapeutics' Other Gross PP&E Adjustments had a median value of $10.8 million in 2024 and averaged $11.1 million.
- Per our database at Business Quant, Fulcrum Therapeutics' Other Gross PP&E Adjustments slumped by 62.88% in 2022 and then spiked by 61.50% in 2023.
- Fulcrum Therapeutics' Other Gross PP&E Adjustments (Quarterly) stood at $14.6 million in 2021, then plummeted by 45.56% to $8.0 million in 2022, then grew by 29.81% to $10.3 million in 2023, then rose by 13.97% to $11.8 million in 2024, then rose by 15.32% to $13.4 million in 2025.
- Its Other Gross PP&E Adjustments was $13.4 million in Q3 2025, compared to $12.9 million in Q2 2025 and $12.4 million in Q1 2025.